Cargando…
Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism
BACKGROUND: Hyperthyroidism has been treated with radioiodine therapy for eight decades, with known benefits and side-effects. No consensus exists on which activity dosage and pre-therapeutic measurements are required for optimal treatment, balancing risk of incomplete response, therapy-induced hypo...
Autores principales: | Nilsson, Joachim N., Elovsson, Rebecca, Thor, Daniel, Calissendorff, Jan, Ardenfors, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036725/ https://www.ncbi.nlm.nih.gov/pubmed/35462539 http://dx.doi.org/10.1186/s13044-022-00126-4 |
Ejemplares similares
-
Predicting outcomes in hyperthyroid cats treated with radioiodine
por: Peterson, Mark E., et al.
Publicado: (2021) -
Clinical Outcome and Costs of Care in Radioiodine Treatment of Hyperthyroidism
por: Hardisty, C. A., et al.
Publicado: (1990) -
Evaluation of Renal Perfusion in Hyperthyroid Cats before and after Radioiodine Treatment
por: Stock, E., et al.
Publicado: (2017) -
Simplified dosimetry for kidneys and tumors in (177)Lu-labeled peptide receptor radionuclide therapy
por: Ardenfors, Oscar, et al.
Publicado: (2022) -
Assessment of symmetric dimethylarginine as a biomarker of renal function in hyperthyroid cats treated with radioiodine
por: Buresova, Eva, et al.
Publicado: (2019)